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Although patients with diabetes mellitus may he afflicted by
cardiomyopathy, its prevalence and nature are controversial .
Studies have shown that fibrosis alters the acoustic properties of
the heart in animals and humans and fist the changes arc
detectable by cardiac tissue characterization with ultrasound . The
present study was performed to characterize myocardial acoustic
properties in patients with insulin-dependerI diabetes to deter
mine whether ultrasound tissue characterization could detect
changes potentially indicative of occult ca :diomyopathy
.
The magnitude of cyclic variation of myocardial ultrasound
integrated baetcscatter and its phase delly with respect to the onset
of the cardiac cycle in the septum and posterior wall of the left
ventricle were measured in 54 patients with diabetes who had no
overt cardiac disease. Conventional echocardiography docu.
Burned normal ventricular systolic function in 96%
. As compared
with results in age-matched patients without diabetes studied
Diabetes mellitus has been associated not only with an
increased risk of atherosclerosis, coronary artery disease
and myocardial infarction (1,2), but also with impairment of
ventricular performance in the absence of ischemia (3,4) or
disproportionate to the extent of infarction
(5,6) or cardi-
omegaly (7,8).
Diabetic cardiomyopathy has been implicated
on the basis of results in studies of laboratory animals with
induced glucose intolerance
(9,10)
.
This condition is thought
to be associated with altered uptake or release of calcium by
the sarcoplasmic reticulum, microvascular coronary disease
or increased cross-linkage of collagen in the heart . However,
the frequency of occurrence, nature and severity of cardio-
myopathy in patients remain controversial (11) despite the
unequivocally excess morbidity and mortality in patients
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previously, cyclic variation of ints% rated backscatter was reduced
(4.6 ± 0 .8 vs. 3.6 ± 1 .4 dB ; p < 0,001). In addition, delay was
significantly increased (0 .86 ± 0.09 vs . 0 .99 ± 0,15) .
The primary analysis of the data focused on differences among
the diabetic patients
. Reduction of cyclic variation of backseatter
was greatest in patients with diabetes who had neuropathy (3 .2 t
1
.0 dB ; p < 0.001) as was the increase in delay (1 .04 ± 0,16, p <
0.001 vs . values In patients without neuropathy). Retinopathy and
nephropathy were associated with abnormal myocardial acoustic
properties as well .
Thus, abnormalities that may reflect fibrosis or other occult
cardiomyopathic changes in diabetic patients without overt heart
disease are readily detectable by myocardial tissue characterisa.
lion with ultrasound and parallel the severity of noncardiac
diabetic complications .
(J Am Coll Cordial 1992;19c1154-62)
with cardiac disease who happen also to have diabetes (12).
Furthermore, the impact of rigorous control of diabetes on
retarding the evolution of myocardial dysfunction has not
yet been elucidated .
This study was performed to characterize the physical
properties of myocardium by ultrasound tissue characteriza-
tion (13-18) in diabetic patients without overt, conventional
manifestations of cardiac disease and to determine whether
!he presence of altered acoustic properties of myocardium
correlates with the presence and severity of noncardiac,
systemic complications of diabetes. We did not undertake a
correlative study with endomyocardial biopsies or coronary
arteriography, because the risks of these invasive proce-
dures were not deemed to be sufficiently low to justify their
performance in patients without any signs or symptoms of
cardiac disease .
Methods
Patients studied. Fifty-four patients with type I diabetes
were recruited from the Washington University Diabetes
Registry . Patients were enrolled after signing informed con-
sent approved by the university's Human Studies Commit-
tee. They exhibited a broad range of age, duration of
diabetes and spectrum of renal, retinal and neurologic com-
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p!ications . Clinical evaluation included a history and physi-
cal examination for assessment of blood pressure . body
mass index, symptoms or signs of peripheral or autonomic
neuropathy, and atherosclerosis, Laboratory tests included
fasting glucose, glycated hemoglobin (by affinity chromatog-
raphy, normal value = 4 .4% to 6 .3%). total cholesterol.
creatinine and 24-h creatinine clearance and urinary protein .
Ophthalmologic examination included :ratduscopic photog-
raphy . Patients were excluded if a history of cardiovascular
disease (symptoms or documented disease) or an abnormal
electrocardiogram (ECG) we obtained
. Myocardial tissue
characterization with ultrasound was implemented by meth-
ods developed previously in our laboratory (13,14) . and
results were analyzed by two investigators U .E.P. and
A .D.W.) who were unaware of any of the characteristics of
the patients .
Control subjects. Although our primary focus was on
data analysis within the group of patients with diabetes and
intragroup comparisons, a preliminary analysis involved
comparisons with historical control subjects
. These included
18 persons who had been referred for echocardiography
because of suspicion of mitral vase orolapsei history of
atypical chest pain or evaluation of ventricular function .
They were shown to be nonhypertensive and nondiabetic by
history and on the basis of conventional laboratory results
.
They were age-matched to the diabetic patient group stud-
ied . The control subjects had been studied previously, with
the same instrumentation as that employed in this study, and
the acquisition of myocardial backscatter data and its anal-
ysis had been identical (19) .
Cardiac Studies
Two-dimensional, M-mode and Doppler echocardiog-
raphy. Before tissue characterization studies were per-
formed, conventional two-dimensional echocardiograms
were acquired (Hewlett-Packard, Sonos 500 system,
2.5 MHz transducer) with multiple standard views (long- and
short-axis, apical four- and two-chamber) for assessment of
cardiac chamber anatomy and systolic left ventricular global
and segmental function . From the parasternal views,
M-mode echocardiograms were obtained to estimate left
ventricular end-diastolic and end-systolic dimensions and
septa) and posterior wall thickness . Left ventricular frac-
tional shortening was calculated as an index
of
systolic
function (20) . Pulsed Doppler echocardiographic measure-
ments of the transmittal flow velocity profile were used to
evaluate diastolic function by positioning a sample volume
initially in the left ventricular inlet at the tip of the mitral
valve as delineated in the apical four-chamber view. Spectral
analysis of the flow velocity profile was displayed at
100 mmls with low filter settings . The peaks of the early
diastolic velocity wave (E) and the late diastolic (A ; atrial
contribution to filling) wave were measured (in cm/s) and
their ratio (E/A) was determined . DecelerLion time of mitral
valve flow from the time of the peak early diastolic velocity
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(E) to the point at which velocity extrapolated to 0 in
mid-diastole was measured in ms. By positioning the sample
volume partially in the left ventricular outflow tract, the
aortic systolic velocity and the mitral diastolic velocity
wave£orms could be recorded simultaneously
. Isovolumetric
relaxation time was measured in ms .
Tissue characterization with ultrasound (backscatter imag-
ing)
. The tissue characterization system employed was de-
veloped and validated previously in our laboratory (21-26)-
With it . signals arriving from each transducer element are
mixed to an intermediate frequency, phase-shifted, delayed
and summed with signals from all other elements
. The
summed analog signal is digitized with 6-bit resolution (or 64
analog-digital steps) and sent to either a standard video
processing path or a special integrated processor before scan
conversion. The time constant of integration is 3 .2 As, and
the dynamic range of the integrated backscatter processor is
approximately 30 dB . The `igitized integrated backscatter
signal is reconverted to analog format and displayed in real
time as a two-dimensional gray scale video image with 5-bit
resolution (32 gray levelsipixel).
A finked M-mode acquisition and analysis system (25,26)
permitted immediate analysis of myocardial integrated back-
scatter data obtained from the septum and posterior wall
(palastemal long-axis view)
. M-mode integrated backscatter
signals with 6-bit resolution were displayed in real time on
the video screen with 5-bit resolution. Single M-mode frames
of integrated backscatter images were recorded with a simul-
taneous ECG signal at a sweep speed of 50 mm/s, frozen on
the images s video screen and analyzed immediately to
provide a measurement of the diastolic to systolic (cyclic
variation) integrated backscatter over the cardiac cycle (27) .
A square analysis cell encompassing approximately 100
pixels was placed in the mid-myocardial region and adjusted
to fit within the boundaries of the myocardial wall at end-
diastole, avoiding the epicardial and endocardial specular
bright echoes . The analysis cell was then moved across the
frozen myocardial M-mode backscatter image for selection
of integrated backscatter values stored in the imaging sys-
tem's memory and computation of spatially averaged inte-
grated backscatter values for the entire intramyocardial
region of interest . A value for integrated backscatter was
computed every 10 ms, displayed instantaneously to pro-
duce a plot
of cyclic variation of integrated backscatter as a
function of time and recorded on 0 .5 in.- (1 .27 cm-) video
tape .
Once the transmit power and time-gain compensation
controls had beep. set for each subject, they were not
changed during the course of data acquisition
. Because the
acquired data represent the relative cyclic variation in the
magnitude of integrated backscatter over four to six cardiac
cycles rather than the absolute level of backscatter, it was
not necessary to calibrate the instrument in absolute terms
as long as the values of integrated backscatter remained
within the dynamic range of the system throughout the
cardiac cycle as was the case for each patient .
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Figure 1 . Top, M-mode integrated backscatter image frozen and
recorded at the bedside at the time of data acquisition
. The cursor
was scrolled across the intramyocordial echoes (posterior wall in
this example) to generate a tracing of the integrated backscatter
(upper panel) over time with a vertical calibration 42 dBldivision .
Cyclic variation led = end-diastole to es = end-systole) is noted
.
Bottom, The delay measurement was obtained by dividing the
interval from the onset of inscription of the electrocardiographic R
Wave to the nadir of the integrated backscatter tracing by the QT
interval
. which yields a dimensionless value .
Magnitude of cyclic variation of backscatter. The magni-
tude of cyclic variation of integrated backscatter was calcu-
lated as the difference in backscatter at the onset of the Q
wave of the ECG and the end of the T wave (end-diastole
and end-systole) in decibels (Fig . I . top). At least five
measurements were averaged to yield a mean vubte
of the
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magnitude of cyclic variation per region for each patient .
This approach has been validated previously (19,25-27) .
Delay of cyclic variation of backscatter . The delay of
regional myocardial cyclic variation of integrated backscat-
ter with respect to the onset of global electrical systole was
expressed in terms of a dimensionless ratio
. Delay was
defined as the interval from the onset of the R wave on the
ECG to the nadir of cyclic variation on the backscatter
recording divided by the QT interval . It was calculated for
the same sites as those used to determine the magnitude of
cyclic variation of integrated backscatter as shown in Figure
I, bottom. Values exceeding unity are indicative of asyn-
chronous regional contractile performance and have been
described in patients with both temporally remote (24) and
acute (25) myocardial infarction .
Statistical Analysis
M-mode, Doppler and measured integrated backscatter
values were calculated off-line from the recorded video
images with the use of a computer-assisted review station
(Nova Microsonics) . Results were tabulated and evaluated
statistically with respect to results of clinical and other
laboratory data in blinded fashion by one of the investigators
(K
.B .S.) . For the purpose of analysis, patients with diabetes
were grouped according to the presence or absence of
peripheral neuropathy . retinopathy
of any extent, nephrop-
athy, the severity of noncardiac complications of diabetes
(clinical score 0 to 8) and with respect to either poor or
good control as judged from glycated hemoglobin values and
duration of diabetes . The summated complication score
devised values were assigned as follows : peripheral
neuropathy (0 = none, I = clinically evident); autonomic
neuropathy (0 = none . I = clinically evident) ; retinopathy
(0 = none, I = background, 2 = proliferative), nephropathy
(0 = none, I = <l g/24 h proteinuria, 2 = nephrotic
syndrome, 3 = serum creatinine >2 mg/dl or end-stage renal
disease) ; hypertension (0 = none, I = present [blood pres-
sure > 150190 mm Hg]). In addition to use of the overall score
as described in the Results section, patients were grouped
according to the presence or absence of neuropathy, reti-
nopathy or nephropathy .
Comparison with control values . The myocardial inte-
grated uackscatter values measured in the heart of patients
with diabetes with or without associated neuropathy, reti-
nopathy or nephropathy and with specific clinical scores
were compared also with values measured in the heart of
age-matched control subjects among a group studied previ-
ously in our laboratory who had no cardiovascular disease or
diabetes. However, the primary analysis focused on severity
of changes within the diabetic patient group with respect to
independent criteria of the severity of noncardiac, systemic
complications.
Statistics. Data were analyzed wiih SAS software imple-
mented on a SUN computer system of the Division of
Biostatistics at Washington University, All continuous data
JACC Vol. 19 . No, 6
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Table 1
. Clinical Characteristics and Complications in 54 Patients With Diahetes
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All valc_s arc mean values x
SD . 'p = 0 .02 . 'p < 0 .001 . 4p < 0.18X11 by analysis of
variant.
§p= 0 .02 . lip < O .Or' by chi-squme'aOMysis beween these
with and without the complicaton .
F -
female
: HbA,C = glycated hemoglobin : 51 = male. n = o : y = yes,
are presented as mean values ± SD
. Chi-square tests were
used to test the hypothesis of equal proportions . Whenever
the necessary assumptions were satisfied. t tests were used
to compare mean values in different groups
. When sample
standard deviations were significantly different, the
Wilcoxon test was used as a nonparametric alternative to the
t test
. Analysis of covariance was employed to confirm that
observed differences in backscatter variables (control sub-
jects vs
. patients with diabetes) were independent of age and
the duration ofdiabetes and independent
of the coexiste-e
of hypertension among the diabetic patients with or without
systemic complications .
Results
Clinical characteristics of The patients studied (Table 1).
Gender, age, blood pressure, dur..eion of diabetes . presence
of
systemic but noncardiac complications, glycated hemo-
globin values and cholesterol values are shown in Table I
.
All 54 patients studied had insulin-dependent diabetes : 18
were hypertensive .
Peripheral neuropathy was present in 28; mild or severe
diabetic retinopathy in 38 and mild, moderate or severe
nephropathy in 23 patients . Nineteen exhibited signs of
autonomic nervous system dysfunction . There wore no
Table 2 . M-Mode and Doppler Echocardiographic Measurements in 54 Patients
statistically significant differences in age, history of
smoking
or glycated hemoglobin values among patients with or with-
out neuropathy, retinopathy or nephropathy . As expected,
patients with diabetes of longer duration had a higher inci-
dence
of complications including neuropathy, retinopathy
and nephropathy
. Hypertension was more common in pa-
tients with nephropathy or neoropathy, but not those with
retinopathy, than in patients without noneardiac complica-
tions .
Results with conventional and
Doppler echocardiography
(Table 2). In general, conventional echoeardiographic find-
ings did not differentiate patients with from those without
noncardiac complications of diabetes . Left ventricular inter-
nal dimensions were normal in all patients studied, and left
ventricular fractional shortening was normal in 96%. Dimen-
sions
did not differ in diabetic patients with or without
peripheral neuropathy or retinopathy, or both . The patients
with nephropathy had smaller internal dimensions than did
those without nephropathy. Left ventricular septa) and pos-
terior wall thickness values were normal
(<1 .2 cm) in 91%
and 96% of patients, respectively
. Those patients with
increased wall thickness were those who were found to be
hypertensive.
As judged from results of Doppler studies (Table
2), none
of the patients exhibited more than physiologic mitral regur-
All values are mean values 5 SD . '0.01 < p < 0.05.Op < 0.01 comparing between those with and without the complication ; DT = moral valve deceleration
rime
: E/A = ratio of the peak-tulhedale diaslolic transmits) flow velocity : FS = left ventricular fraetional
shortening;
IVR = isovolumetdc relaxation period ;
LVDD = left ventricular and-diastolic dimension: LVSD = left ventricular end-systolic dimension
.
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Pr-al
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Present
In = 231
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In = 161
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Table
3 .
Myocardial Backscatter Measurements in 54 Patients With Diabetes and 18 Control Patients
gitation, and none exhibited stenosis or appreciable regurgi-
tation at the site of any valve
. The PA ratio of mitral valve
flew did correlate inversely with the clinical complications
score, reflecting manifestations of diastolic dysfunction of
the left ventricle (r = -0
.46; p < 0.001) . Patients with
nearopathy or nephropathy had significantly lower E/A
values than did those without these noncardiac systemic
complications . The isovolumetric relaxation time in diabetic
patients was higher than values reported for normal persons
(28), although this index of diastolic function generally did
not differ among the patients with or without noncardiac,
systemic complications. Mitral valve deceleration time was
normal in all patients and did not differentiate those with
from those without systemic complications of diabetes .
Thus, some of the Doppler indexes of diastolic function were
abnormal in patients with noncardiac complications of dia-
betes as has, been previously reported (29) .
Results of tissue characterization with ultrasound (analysis
of backscatter) (Table 3)
. When backscatter results in the
entire group of diabetic patients (age 35 ± 10
.5 years) were
compared with values from the nondiabetic, normotensive,
age-matched control subjects (10 male, 8 female , studied
previously (age 37.5 ± 12 .4; p = NS) who had normal
ventricular dimensions (4 .6 ± 0 .3 and 3 .1 ± 0 .2 cm in
diastole and systole, respectively), fractional shortening
(31 .7 ± 2
.5%) and regional function, significant differences in
cardiac acoustic properties were evident (Fig. 2) . Cyclic
variation of integrated backscatter in control subjects ex-
ceeded that in diabetic patients in the septum (4.6 t 0.8 vs
.
3 .6 '- 1 .4 dB ; p = 0.001) and the posterior wall (4 .8 ± 0 .8 vs .
4.0 ± 1
.4 dB : p = 0.02) . Delay values in the two sites were
lower in control subjects than in diabetic patients in the
septum (0.86 ± 0 .07 vs . 0 .97 ± 0
.19 ; p = 0.05) and the
posterior wall (0
.86 ± 0.09 vs. 0.99 ± 0 .15 ; p = 0.001). To
exclude possible confounding effects of hypertension on the
data, the 35 normotensive diabetic subjects were evaluated
separately; these patients still exhibited significantly pro-
longed delay anal reduced cyclic variation values (except for
cyclic variation in the posterior wall
; p = 0 .07). Further-
more, measurement of backscatter values differentiated
groups of diabetic patients from each other strikingly (those
with and those without the complications and those with low
3ACC Vol . 19, No . 6
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0.001 versus absence of the complication (after adjustment for hypertension (-ralysis of cocarioncel)
. Dip = delay of cyclic variation in the posterior wall : Ds =
delay of cyclic variation in the septum : top = cyclic variation
of integrated backscatter in the posterior wall : [Bs = cyclic variation of integrated bcekscaner in
the septum.
compared with high overall complication scores)
. Diabetic
patients with peripheral neuropathy (Table 3) had signifi-
cantly lower values of cyclic variation of integrated back-
scatter in both the septum and the posterior wall than did
patients without neuropathy (Fig . 3)
. They also had signifi-
cantly prolonged values of delay in the septum compared
with values in patients without nemopathy . Diabetic patients
with retinopathy had significantly lower values of cyclic
variation of backscatter n the septum (Fig . 4) and greater
delay values than those of patients without retinopathy
.
These significant differences remained after adjustment for
hypertension as a covariale. However, among patients with
or without nephropathy none of the acoustic variables
exhibited significant differences when adjusted for hyperten-
sion .
Although differences in backscatter variables among
groups with and without the systemic complications of
diabetes were significant, there was some overlap, preclud-
ing the definition of precise cutoff values of backscatter with
narrow confidence limits for separation of individual pa-
Figure 2 . Comparison of backscatter variables (cyclic variation in
dB . upper panels and delay, lower panels) in the septum and
posterior wall in the control group (patients without diabetes studied
previously) and in the group of diabetic patients evaluated in the
present study. **0 .001 < p < 0.01 versus control subjects : *0.01 <
p < 0.05 versus control subjects
: error bars represent SD .
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Figure 3 .
Consonrisons of cyclic variation and delay values in each
myocardial wall in patients with diabetes with (present) and those
without (Absent) neuropathy.'"'p < 0.001 compared with values in
patients without neuropathy : "0.001 c p c 0 .01 compared with
values in
patients wnhonl neuropathy .
tie its . Nevertheless, the observed differences in backscatter
variables among patients with and without neuropathy and
retinopaihy were significant and independent of the presence
or absence of hypertension . Overall, cyclic variation of
backscatter in both the septum and the posterior wall corre-
lated inversely (r = -0.32. p = 0 .01 and r = -0.40, p =
0.002) with the Cl aical complications score whereas delay
values correlated directly with the complications score (r =
0 .35, p = 0.009 and r = 0.41, p = 0.002). Thus . altered
magnitude and delay of cyclic variation of backscatter
consistent with occult myopathic processes reflected by
changes in acoustic properties of the heart were hallmarks of
the presence of diabetes associated with severe, noncardiac
complications despite the presence of normal ventricular
size and function as judged from results of conventional
echocardiographic analysis (Fig. 5) .
Discussion
Deteetion of abnormal myocardial acoustic properties .
Our results indicate that yntic,^,ls with insdlisdep'mdent
diabetes associated with noncardiac systemic complications
often manifest occult changes suggestive of cardiom) apathy
as well, detectable by quantitative tissue characterization of
the heart with ultrasound . The abnormally low values of
cyclic variation of integrated backscatter and its consider-
able delay are likely to reflect early cardiomyopathic
Figure 5 .
Comparisons of cyclic variation and delay values in each
myocardial wall among patients with diabetes with (present) and
without (Absent) retinopathy . *"p <11 .01)l compared with values in
these without retinopathy ; "0.001 < p < 0.01 compared with values
in those without retinopathy.
Ratinupribs Ruiaapathy
non
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changes perhaps attributable to deposition of collagen in the
heart as is the case . with diabetes, in other organs 150-33) .
Detection of such changes may be analogous to detection
and quantification of glycated hemoglobin (AIC) in that both
may provide indexes of the biologic impact of the disorder
integrated over time . It is of course possible that the changes
we observed are related to hyperinsulinemia rather than to
diabetes itself. Studies are in progress to correlate changes
detectable by ultrasound backscatter interrogation of the
heart with prevailing insulin levels and the severity of
diabetes in norinsulimdependent patients to clarify this
issue .
With backscatter imaging, abnormal acoustic properties
in tissue can be recognized despite preserved normal systolic
function and normal left ventricular chamber dimensions
.
Early signs of diastolic dysfimetion were suggested by snore
of the Doppler measurements in the diabetic patients as well .
consistent with previous observations in young diabetic
patients (29) . However, early structural derangements such
as those implied by the abnoraal backscatter data in our
patients have not been detected previously with noninvasive
techniques or associated with the presence and severity of
noncardiac complications of diabetes .
Backscatter mad callow. We (30) have previously shown
that quantitative tissue characterization with ultrasound
detects altered physical characteristics of myocardaun in
experimental animals and humans . Marked increases in
absolute values of integrated backscatter are seen in zones of
temporally remote infarction and correlate with increases in
collagen content delineated biochemieally . Similar increases
have been correlated with cardiomyopathic changes second-
ary to doxorubicin (31)
. In the heart of Syrian hamsters with
hereditary cardiomyopathy, backscatter values increase
with the age of the afflicted animal and in
association
with
the development of fibrosis (32). Absolute backscatter val-
ues in the human heart correlate with the collagen content of
tissue (34) as, judged from higher values in the right than in
the left ventricle and the correspondingly higher collagen
content of the right ventricular wall (35).
Cyclic variation d idegroted backscatter. Measurement
of cyclic variation of backscatter permits assessment of
dynamic properties of the heart reflecting the physical state
of the tissue (36). Cyclic variation is decreased in hypeki-
netic regions of temporally remote myocardial infarcts in the
heart of experimental animals (22) cad patients (24). Hearts
with end-stage dilated cardiomyopatley exhibit widespread,
markedly decreased cyclic variation of backscatter (23) .
These observations and those of Masuyama et al . (37), who
evaluated cyclic variation as afunCtion of age of she subject,
are consistent with the view that decreased cyclic variation
of backscauer may reflect the extent of deposition of colla-
gen in the heart. Our results are consistent with the hypoth-
esis that diabetic patients with severe
disease have altered
myocardial acoustic properties consistent with increased
accumulation or cross-linkage of collagen in the heart de-
tectable by tissue characterization with ultrasound and pre-
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ceding deterioration of cardiac function detectable by con-
ventional echocardiography .
Reduced cyclic variation of backscatter may, of course,
not be tantamount to accumulation of collagen . Regions of
severe hypokinesia or akinesia in the heart of patients with
acute myocardial infarction may exhibit recovery of cyclic
variation of backscatter after coronary recanalization with
thrombolytic drugs
(25) .
Transient reductions in cyclic vari-
ation accompany rejection of cardiac allografts (38) with
recovery of cyclic variation inducible by intensive antirejec-
tion therapy . We cannot completely exclude the possibility
that the diabetic patients studied could have had macrovas-
eular or diffuse microvascular coronary disease . Our results
do not imply that the abnormal myocardial acoustic proper-
ties detected in the diabetic patients occur in the absence of
occult coronary disease . In fact, they could be a reflection of
such occult disease and a marker of it . However, the diffuse
nature of the altered acoustic properties of the heart that
were detected, the lack of abnormal segmental systolic
ventricular function and the lack of ECG abnormalities in the
patients studied coupled with the lack of symptoms or signs
of coronary artery disease lead us to a different concNJSimt .
We believe that the abnormal myocardial backscatter in-
dexes seen in the presence of preserved segmental and
global systolic function at rest are best explained as reflect-
ing abnormalities of a structural nature, particularly deposi-
tion of collagen_ Further support for this interpretation
comes from the observation that an ECG exercise stress test
obtained retrospcctively in the 12 patients with the most
abnormal backscatter indexes was abnormal in only I patient
and that results of echocardiographic stress tests were
negative as well. One other patient with echocardiographic
criers iaditative of old infarction underwent cardiac cash .
eterization and was found to have coronary artery disease .
Collagen deposition in diabetes. Deposition of collagen is
a well recognized characteristic in diverse organs it. diabetic
JACC Vol . 19. No.6
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Figure
S
. Comparison of a typical M-mode inte-
grated backscatter image liom a patient wilo diabe-
tes with a low clinical complications score (left panel,
posterior wall cyclic variation of 5 dB with normal
delay) with that from a patient with diabetes with a
high score (tight panel, posterior wall cyclic varia-
tion of 1 .8 dB with prolonged delay). Results differ
despite comparable and normal segmental systolic
function measured conventionally in both patients.
patients . Monnier et al . (33) demonstrated increased fluores-
cence attributable to collagen associated with severe dia-
betic retinopathy, stiffened arterial walls and diminished
mobility of joints. Collier et al. (35) showed that skin
thickness reflected collagen content and was increased in
patients with type I diabetes. Dominiczak et al. (40) demon-
strated increased cutaneous fluorescence attributable to col-
lagen in such patients in relation to the duration of disease
and the age of the patient .
Brownlee et al . (41) suggested that deposition of collagen
in diabetic patients is a reflection of chronic hyperglycemia .
They postulate that glucose combines with the amino groups
of proteins to form Schiff bodies that rearrange into Amadori
products eventually forming irreversible, glycosylation
products. Such products can promote cross-linkage of col-
lagen and accumulation of matrix proteins . Our results are
consistent with the hypothesis that accumulation of collagen
is responsible for alterations in the acoustic properties of the
heart in diabetic patients with severe or prolonged disease
that are, in fact, preelinical signs of occult cardiomyopathy .
Direct his' ologic evidence of increased collagen in tissue was
not acquired because myocardial biopsy (with its morbidity
of ?3 .4%) was not deemed justified (42) in these patients
who had no conventional signs or symptoms of cardiac
disease .
Implications with respect to diabetic cardiomyopathy . In-
creased stiffness of myocardium occurs in the heart of
animals with experimentally induced diabetes and is
associated with deposition of material with histochemical
characteristics of collagen
(43).
Our group (5) has docu-
mented increased impairment of cardiac functino and more
severe congestive heart failure in diabetic than in nondia-
betie patients with acute myocardial
infarction
of compara-
ble extent. Similar results were obtained in a large group of
patients as well (44).
Delineation of cardiomyopathy in diabetic patients has
JACC Vol. 19. No. 6
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been elusive even when the left ventricular ejection fraction
ohovotovooor of myooardiunr moor,
thrloborolony to hr betide. JAn
s« Eobocardiagr 1999:1^_94-305.
response exercise is reduced. As Borow et al . 145) have
15 Dlskmsky B
. Collie : SM . Skonton DJ, Pmsad NV . Varimion of [aft
shown, patients with diabetes exhibit normal contractile
vetdnculormyocardial gray levelontwo-dimensionalechxarditor l msas
reserve after stimulation with dubutamine . Furthermore,
rcsuttofcrrdiaccontrxliuaCircuwiont9ga :70972-71
both load- and heart rate-independent indexes of contractil-
16 .a1asuyam,T .st .GoarF.'rye'TLOppenbeimG .echniugerl
.PoppRL.
ity
Ulirasonto tissue chancreriralion of human hyparmphied h0..uls in is,,
are apparently normal. However, recent data from the
weft cardiac cycle depeMem variation in integrated back-la, Ciru-
Framingham study
(46) with the use of two-dimensional
lotion 19119111 :4,15-34 .
echocardiography
support the hypothesis that cardiomyop-
n . Rhyne TL, Sager KB, Warm SL
. Holster G. The myocardial sigma unc :
achy is present in at least some diabetic patients .
ah,olute n cksemter. cyclic variatio n, frequency v fizai n and s,anstics.
tionie:IU1--22,
Conclusions . Our results indicate that application of
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gestive of cardiomyopathy at a time wmen systolic ventricu-
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